B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sch23390

126 PubMed studies analyzed · Evidence Score: 42.3

Research Domains

Sch23390 has been studied across 13 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Memory, 🧠 Learning, 🧘 Stress & Anxiety. The primary research focus is 🌤️ Mood & Depression with 94% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sch23390 is generated deterministically from 126 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.